CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Aquaman who wrote (406)	9/18/1998 12:14:00 PM
From: Aquaman	Read Replies (1) of 675

PR Newswire- Aug 26,98 "....important advances in its Gilial Growth Factor 2 (FFf2) program for multiple sclerosis (ms).......Positive pre-clinical data support our expectaion of filing an IND for GGF2 before the end of l999.....multiple sclerosis is a degenerative disease of the central nervous system that afflicts more than 350,000 Americans" I put my money where my mouth is, I'm in for run..... I hope its a UP run!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next